# Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO

> **NCT01930331** · PHASE4 · COMPLETED · sponsor: **Ifakara Health Institute** · enrollment: 60 (actual)

## Conditions studied

- Plasmodium Falciparum
- Malaria, Falciparum

## Interventions

- **DRUG:** artemisinin/naphthoquine
- **DRUG:** dihydroartemisinin/piperaquine phosphate

## Key facts

- **NCT ID:** NCT01930331
- **Lead sponsor:** Ifakara Health Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-07
- **Primary completion:** 2014-07-27
- **Final completion:** 2015-06-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01930331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01930331, "Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01930331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*